Adjuvant therapy in hepatocellular carcinoma: the IMbrave050 trial - Authors' reply

Affiliations

¹ Division of Surgery and Surgical Oncology, National Cancer Centre Singapore and Duke-NUS Medical School, Singapore; Program in Translational and Liver Cancer Research, National Cancer Centre Singapore, Singapore 168583. Electronic address: pierce.chow@duke-nus.edu.sg.
² Genentech, San Francisco, CA, USA.
³ Department of Surgery, Division of Surgical Oncology, The University of Texas Southwestern Medical Center, Dallas, TX, USA.

Comment

Pierce K H Chow et al. Lancet. 2024.

. 2024 Aug 17;404(10453):657-658.

doi: 10.1016/S0140-6736(24)00801-8.

¹ Division of Surgery and Surgical Oncology, National Cancer Centre Singapore and Duke-NUS Medical School, Singapore; Program in Translational and Liver Cancer Research, National Cancer Centre Singapore, Singapore 168583. Electronic address: pierce.chow@duke-nus.edu.sg.
² Genentech, San Francisco, CA, USA.
³ Department of Surgery, Division of Surgical Oncology, The University of Texas Southwestern Medical Center, Dallas, TX, USA.

No abstract available

Comment on

Adjuvant therapy in hepatocellular carcinoma: the IMbrave050 trial.
Shin H, Lee JH. Shin H, et al. Lancet. 2024 Aug 17;404(10453):654-655. doi: 10.1016/S0140-6736(24)00797-9. Lancet. 2024. PMID: 39153810 No abstract available.
Adjuvant therapy in hepatocellular carcinoma: the IMbrave050 trial.
Donadon M, Di Martino M, Rigamonti C. Donadon M, et al. Lancet. 2024 Aug 17;404(10453):655-656. doi: 10.1016/S0140-6736(24)00798-0. Lancet. 2024. PMID: 39153812 No abstract available.
Adjuvant therapy in hepatocellular carcinoma: the IMbrave050 trial.
Chen Z, Lan X, Du C, Xiao H. Chen Z, et al. Lancet. 2024 Aug 17;404(10453):656. doi: 10.1016/S0140-6736(24)00799-2. Lancet. 2024. PMID: 39153813 No abstract available.
Adjuvant therapy in hepatocellular carcinoma: the IMbrave050 trial.
Rose S, Ashraf MU, Premkumar M. Rose S, et al. Lancet. 2024 Aug 17;404(10453):656-657. doi: 10.1016/S0140-6736(24)00800-6. Lancet. 2024. PMID: 39153814 No abstract available.